HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,213-1,224 of 1,979
Other study type icon
CompletedNCT00181831

Spectroscopy in Children and Adolescents With Bipolarity

Official study title

Proton Magnetic Resonance Spectroscopy in Children and Adolescents With Bipolar Disorder

This study has finished and is no longer accepting participants.

In Boston
Bipolarity, ADHDObservational studyAges 6–17
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00926393

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in people with Depression in bipolarity

Official study title

A Phase IV, Multi-center, Double-blind, Double-dummy, Randomized, Parallel-group Study to Compare the Tolerability of Quetiapine Fumarate Immediate Release (Seroquel IR) With Quetiapine Fumarate Extended Release (Seroquel XR) During Initial Dose Escalation in Patients With Bipolar Depression

This study has finished and is no longer accepting participants.

Location not clearly listed
Bipolarity, DepressionMedication studyAges 18–50
Countries
Sponsor
AstraZeneca
Drug study icon
CompletedNCT00134459

Study Evaluating Bifeprunox in Depression in bipolarity

Official study title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-Group Study of Bifeprunox in the Treatment of Depression in Outpatients With Bipolar Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Drug study icon
CompletedNCT00982020

Study in Adolescents With Schizophrenia or Bipolarity

Official study title

A Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents With Bipolar I Disorder (Manic or Mixed Episodes) or Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Lauderhill
Bipolarity, SchizophreniaMedication studyAges 13–17
Countries
United States, Poland, Russia
Sponsor
Eli Lilly and Company
Drug study icon
CompletedNCT00080314

Aripiprazole in people with Bipolarity type I With a Major Depression Episode

Official study title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode

This study has finished and is no longer accepting participants.

Multiple locations, including Tuscaloosa
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT01979133

Icariin for Bipolarity and Co-Occurring Substance Use Disorders

Official study title

A Proof of Concept Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders

This study has finished and is no longer accepting participants.

In Dallas
Bipolarity, AddictionMedication studyAges 18–70
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Drug study icon
CompletedNCT00277654

Risperidone Monotherapy for anxiety

Official study title

A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder

This study has finished and is no longer accepting participants.

In Cincinnati
Bipolarity, AnxietyMedication studyAges 18+
Countries
United States
Sponsor
Lindner Center of HOPE
Drug study icon
CompletedNCT02670538

Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for depression

What is this study about?

Researchers compared Cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States, Bulgaria, Croatia, + 4 others
Sponsor
Forest Laboratories
Drug study icon
CompletedNCT03187769

Efficacy of ALKS 3831 on Body Weight for schizophrenia

Official study title

A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults With Schizophrenia, Schizophreniform, or Bipolar I Disorder Who Are Early in Their Illness

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
Bipolarity, SchizophreniaMedication studyAges 16–40
Countries
United States, United Kingdom, Austria, + 9 others
Sponsor
Alkermes, Inc.
Drug study icon
CompletedNCT01409096

Study Using Pregnenolone to Treat Depression in bipolarity

Official study title

A Randomized, Double Blind, Placebo-controlled Trial of Pregnenolone for Bipolar Depression

This study has finished and is no longer accepting participants.

In Dallas
Bipolarity, DepressionMedication studyAges 18–75
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Drug study icon
CompletedNCT01528839

Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Depression in bipolarity

Official study title

Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.

This study has finished and is no longer accepting participants.

Multiple locations, including Los Angeles
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States, Germany
Sponsor
Charite University, Berlin, Germany

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.